ERNAW Ernexa Therapeutics Inc. - Warrants
$0,08
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 6, 2026
Rango 52S
$0–$0
28% of range
Calificación del Analista
—
Precio Objetivo
—
P/E (TTM)
—
ROE
-411.6%
Margen de Beneficio Neto
—
ERNAW Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.08
Capitalización Bursátil
—
P/E (TTM)
—
BPA (TTM)
$-2.24
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-411.6%
Deuda/Capital
—
Rango 52S
$0 – $0
ERNAW Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
2016-12-31
→
2024-12-31
BPA
$-2.24
2020-12-31
→
2025-12-31
Flujo de caja libre
$-7M
2016-12-31
→
2025-12-31
Márgenes
—
2024-12-31
→
2024-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ERNAW
Mediana de Pares
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ERNAW
Mediana de Pares
ROA
-253.7%
—
ROE
-411.6%
—
ROIC
-386.9%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ERNAW
Mediana de Pares
Current Ratio (Ratio corriente)
1.0
—
Quick Ratio (Ratio Rápido)
0.6
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ERNAW
Mediana de Pares
Revenue YoY (Ingresos interanuales)
755.9%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
-77.3%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ERNAW
Mediana de Pares
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $582.0K | $68.0K | $0 | · | $6M | $20M | $23M | $21M | $22M | $25M | $26M | |
| Cost of Revenue | · | $96.0K | $236.0K | $0 | · | · | · | · | · | · | · | · | |
| Gross Profit | · | $486.0K | $-168.0K | $0 | · | · | · | · | · | · | · | · | |
| R&D Expense | · | · | · | · | · | $2.0K | $26.0K | $72.0K | $139.0K | · | · | · | |
| SG&A Expense | $5M | $13M | $15M | $17M | $15M | $3M | $13M | $14M | $16M | $16M | $18M | $18M | |
| Operating Expenses | $9M | $16M | $21M | $33M | $114M | $7M | $22M | $23M | $23M | $25M | $31M | $31M | |
| Operating Income | $-9M | $-16M | $-21M | $-33M | $-114M | $-7M | $-2M | $203.0K | $-1M | $-2M | $-7M | $-5M | |
| Interest Expense | · | · | $614.0K | $30.0K | · | · | · | · | · | · | · | $223.0K | |
| Other Non-op | $215.0K | $70.0K | $-334.0K | $-1M | $899.0K | $-43.0K | $-258.0K | $-526.0K | $391.0K | $-31.0K | $-319.0K | $-204.0K | |
| Pretax Income | $-14M | $-45M | $-22M | $-25M | $-122M | $-7M | $-2M | $-323.0K | $-1M | $-3M | $-7M | $-5M | |
| Income Tax | $-45.0K | $30.0K | $-3.0K | $45.0K | $64.0K | $0 | $27.0K | $-64.0K | $66.0K | $38.0K | $12.0K | $84.0K | |
| Net Income | $-14M | $-45M | $-22M | $-25M | $-123M | $-7M | $-2M | $-259.0K | $-1M | $-3M | $-7M | $-5M | |
| EPS (Basic) | $-2.24 | $-48.96 | $-4.08 | $-8.06 | $-56.61 | $-0.41 | · | · | · | · | · | · | |
| EPS (Diluted) | $-2.24 | $-48.96 | $-4.08 | $-8.06 | $-56.61 | $-0.41 | · | · | · | · | · | · | |
| Shares (Basic) | 6,307,000 | 910,000 | 5,314,000 | 3,051,000 | 2,165,000 | 17,588,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 6,307,000 | 910,000 | 5,314,000 | 3,051,000 | 2,165,000 | 17,588,000 | · | · | · | · | · | · | |
| EBITDA | $-9M | $-16M | · | $-33M | $-114M | $-6M | · | $3M | $915.0K | $609.0K | $-4M | $-2M |
Balance general 27
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $2M | $8M | $11M | $17M | $2M | $3M | $3M | $3M | $6M | $3M | $7M | |
| Receivables | · | · | · | · | $684.0K | $0 | $1M | $1M | $714.0K | $928.0K | $919.0K | $2M | |
| Prepaid Expense | $404.0K | $186.0K | $2M | $1M | $1M | $102.0K | $526.0K | $517.0K | $680.0K | $1M | $978.0K | $742.0K | |
| Current Assets | $3M | $2M | $10M | $14M | $19M | $2M | $6M | $7M | $10M | $11M | $9M | $15M | |
| PP&E (Net) | $94.0K | $85.0K | $493.0K | $236.0K | $670.0K | $594.0K | $3M | $5M | $4M | $3M | $4M | $3M | |
| PP&E (Gross) | $291.0K | $257.0K | $607.0K | $268.0K | $877.0K | $714.0K | $12M | $15M | $14M | $14M | $16M | $23M | |
| Accum. Depreciation | $197.0K | $172.0K | $114.0K | $32.0K | $207.0K | $120.0K | $9M | $11M | $10M | $11M | $12M | $19M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $696.0K | $667.0K | $1M | $937.0K | $909.0K | $1M | |
| Intangibles | · | · | · | · | · | · | $696.0K | $667.0K | $1M | $29.0K | $79.0K | $129.0K | |
| Other Non-current Assets | $110.0K | $118.0K | $120.0K | $1M | $488.0K | $50.0K | $97.0K | $103.0K | $16.0K | $92.0K | $124.0K | $57.0K | |
| Total Assets | $6M | $5M | $49M | $22M | $32M | $13M | $14M | $15M | $17M | $17M | $16M | $22M | |
| Accounts Payable | $1M | $2M | $1M | $2M | $2M | $1M | $835.0K | $271.0K | $390.0K | $247.0K | $211.0K | $617.0K | |
| Accrued Liabilities | $898.0K | $1M | $2M | $4M | $1M | $1M | $490.0K | $444.0K | $418.0K | $697.0K | $670.0K | $969.0K | |
| Current Liabilities | $3M | $3M | $7M | $8M | $4M | $3M | $6M | $4M | $11M | $7M | $5M | $7M | |
| Capital Leases | $277.0K | $477.0K | $33M | $887.0K | $2M | $2M | $3M | $41.0K | $164.0K | $259.0K | $138.0K | $30.0K | |
| Other Non-current Liabilities | $43.0K | $111.0K | $84.0K | $94.0K | $48.0K | $23.0K | $26.0K | · | $52.0K | $12.0K | $0 | $7.0K | |
| Total Liabilities | $3M | $4M | $47M | $10M | $6M | $5M | $9M | $8M | $11M | $13M | $13M | $11M | |
| Long-term Debt | · | · | · | · | · | $2M | · | $4M | $5M | $8M | $7M | $5M | |
| Total Debt | · | · | · | · | · | $2M | · | $1M | $5M | $3M | $1M | $2M | |
| Common Stock | $2.0K | $17.0K | $27.0K | $26.0K | $13.0K | $0 | $14.0K | $14.0K | $13.0K | $11.0K | $9.0K | $462.0K | |
| Paid-in Capital | $248M | $233M | $189M | $177M | $166M | $0 | $137M | $137M | $135M | $132M | $129M | $128M | |
| Retained Earnings | $-246M | $-232M | $-187M | $-165M | $-141M | $-18M | $-131M | $-129M | $-129M | $-128M | $-125M | $-118M | |
| Treasury Stock | · | · | · | · | · | $456.0K | $456.0K | $456.0K | $456.0K | $456.0K | $456.0K | $456.0K | |
| AOCI | · | · | · | · | · | $245.0K | $268.0K | $200.0K | $345.0K | $223.0K | $172.0K | $479.0K | |
| Stockholders' Equity | $2M | $2M | $2M | $12M | $26M | $8M | $10M | $7M | $6M | $4M | $4M | $11M | |
| Liabilities + Equity | $6M | $5M | $49M | $22M | $32M | $13M | $14M | $15M | $17M | $17M | $16M | $22M | |
| Shares Outstanding | 314,000 | 3,426,000 | 5,410,000 | 5,127,000 | 2,601,000 | 0 | 2,901,000 | 2,875,000 | 2,521,000 | 2,261,000 | 1,849,000 | 92,370,000 |
Flujo de Efectivo 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $65.0K | $139.0K | $84.0K | $161.0K | $117.0K | $98.0K | $3M | $3M | $2M | $3M | $3M | $3M | |
| Stock-based Comp | $1M | $2M | $1M | $3M | $5M | $91.0K | $206.0K | $443.0K | $457.0K | $419.0K | $456.0K | $282.0K | |
| Deferred Tax | $-48.0K | $27.0K | $-4.0K | $-9M | $-7M | $-322.0K | $-4.0K | $69.0K | $-34.0K | $-12.0K | $-10.0K | $-23.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $29.0K | · | $50.0K | $50.0K | $181.0K | |
| Other Non-cash | $6M | $27M | · | $9M | $101M | · | · | $-2M | $-1M | $-348.0K | $-504.0K | $-4M | |
| Operating Cash Flow | $-7M | $-16M | $-20M | $-21M | $-23M | $-8M | $3M | $1M | $549.0K | $23.0K | $-4M | $-6M | |
| CapEx | $37.0K | $369.0K | $19.0K | $297.0K | $154.0K | $39.0K | $128.0K | $648.0K | $728.0K | $427.0K | $991.0K | $835.0K | |
| Investing Cash Flow | $-37.0K | $-365.0K | $-19.0K | $-47.0K | $-23M | $-39.0K | $-1M | $-2M | $-1M | $-840.0K | $-2M | · | |
| Debt Issued | · | · | · | · | · | $3M | · | $4M | $50.0K | $3M | $7M | $6M | |
| Net Debt Issued | · | · | · | · | · | $375.0K | · | $-1M | $-3M | $673.0K | $2M | · | |
| Stock Issued | $5M | $1M | · | $20M | $0 | $0 | · | $1M | $2M | $3M | · | $6M | |
| Net Stock Activity | $5M | $1M | · | $20M | $52M | · | · | $1M | $2M | $3M | · | $6M | |
| Financing Cash Flow | $7M | $6M | $17M | $20M | $62M | $5M | $-1M | $-303.0K | $-1M | $3M | $2M | · | |
| Net Change in Cash | · | · | · | · | · | $-3M | $623.0K | $-592.0K | $-2M | $2M | $-4M | $2M | |
| Taxes Paid | $3.0K | $3.0K | $4.0K | $15.0K | $1.0K | $0 | $26.0K | $17.0K | $36.0K | $47.0K | $69.0K | $35.0K | |
| Free Cash Flow | $-7M | $-16M | · | $-21M | $-24M | · | · | $717.0K | $-179.0K | $-404.0K | $-5M | $-7M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-7M |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 83.5% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | · | -2693.1% | · | · | · | -108.8% | · | 0.87% | -6.6% | -10.2% | -28.1% | -18.2% | |
| Net Margin | · | -7652.8% | · | · | · | -76.1% | · | -1.1% | -5.1% | -13.1% | -29.5% | -19.3% | |
| Pretax Margin | · | -7647.6% | · | · | · | -76.2% | · | -1.4% | -4.8% | -12.9% | -29.4% | -19.0% | |
| EBITDA Margin | · | -2669.2% | · | · | · | -108.8% | · | 12.7% | 4.3% | 2.7% | -15.5% | -7.7% | |
| ROA | -253.7% | -163.7% | · | -91.4% | · | -49.4% | · | -1.7% | -6.5% | -17.7% | -37.4% | -26.7% | |
| ROE | -411.6% | 203.9% | · | -235.0% | · | -83.2% | · | -3.8% | -22.4% | -73.9% | -97.8% | -50.0% | |
| ROIC | -386.9% | -922.1% | · | -274.9% | · | -218.5% | · | 2.1% | -14.1% | -32.7% | -140.4% | -36.8% |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.8 | · | 1.8 | · | 0.7 | · | 1.7 | 0.9 | 1.6 | 1.8 | 2.1 | |
| Quick Ratio | 0.6 | 0.6 | · | 1.5 | · | 0.4 | · | 0.9 | 0.4 | 1.0 | 0.8 | 1.3 | |
| Debt / Equity | · | · | · | · | · | 2.4 | · | 0.1 | 0.9 | 0.7 | 0.3 | 0.2 | |
| LT Debt / Equity | · | · | · | · | · | 0.6 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -21.3 |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | 0.6 | · | 1.5 | 1.3 | 1.3 | 1.3 | 1.4 | |
| Receivables Turnover | · | · | · | · | · | 8.8 | · | 25.1 | 25.9 | 24.2 | 15.8 | 18.4 |
Tasas de Crecimiento 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | 755.9% | · | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | -77.3% | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $632.0K | $582.0K | $68.0K | $0 | $9M | $6M | $20M | $23M | $21M | $22M | $25M | $26M | |
| Net Income TTM | $-14M | $-45M | $-22M | $-25M | $-123M | $-7M | $-2M | $-259.0K | $-1M | $-3M | $-7M | $-5M |
Estado de resultados 16
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $1.0K | $487.0K | $47.0K | $47.0K | $17.0K | $51.0K | · | $0 | $0 | $0 | · | |
| Cost of Revenue | $0 | · | · | $0 | · | $0 | $-60.0K | $95.0K | $61.0K | $66.0K | $120.0K | · | $50.0K | $0 | $0 | · | |
| Gross Profit | · | · | · | · | · | $1.0K | $547.0K | $-48.0K | $-14.0K | $-49.0K | $-69.0K | · | $-50.0K | $0 | $0 | · | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| SG&A Expense | $1M | $1M | $958.0K | $1M | $1M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $6M | |
| Operating Expenses | $4M | $2M | $2M | $3M | $3M | $3M | $3M | $5M | $6M | $6M | $5M | $5M | $5M | $5M | $8M | $14M | |
| Operating Income | $-4M | $-2M | $-2M | $-3M | $-3M | $-3M | $-2M | $-5M | $-6M | $-6M | $-6M | $-5M | $-5M | $-5M | $-8M | $-14M | |
| Other Non-op | $-1.0K | $479.0K | $-6.0K | $-123.0K | $-135.0K | · | · | · | · | $42.0K | $-1.0K | $-280.0K | $-95.0K | $-11M | $993.0K | $10M | |
| Pretax Income | $-4M | $-2M | $-1M | $-3M | $-8M | $-6M | $-27M | $-6M | $-7M | $-6M | $-6M | $-5M | $-5M | $-4M | $-7M | $-3M | |
| Income Tax | · | $-62.0K | $6.0K | $3.0K | $8.0K | $11.0K | $12.0K | $3.0K | $4.0K | $-4.0K | $-8.0K | $4.0K | $5.0K | $40.0K | $5.0K | $0 | |
| Net Income | $-4M | $-2M | $-1M | $-3M | $-8M | $-6M | $-27M | $-6M | $-7M | $-6M | $-6M | $-5M | $-5M | $-4M | $-7M | $-3M | |
| EPS (Basic) | $-3.40 | $-1.33 | $-0.15 | $-15.19 | $-0.15 | $41.31 | $-73.70 | $-15.34 | $-1.23 | $-1.14 | $-1.03 | $-0.85 | $-1.06 | $-0.91 | $-2.49 | $-1.16 | |
| EPS (Diluted) | $-3.40 | $-1.33 | $-0.15 | $-15.19 | $-0.15 | $41.31 | $-73.70 | $-15.34 | $-1.23 | $-1.14 | $-1.03 | $-0.85 | $-1.06 | $-0.91 | $-2.49 | $-1.16 | |
| Shares (Basic) | 1,183,000 | -60,459,000 | 8,226,000 | 207,000 | 53,361,000 | -5,222,000 | 361,000 | 361,000 | 5,410,000 | -10,526,000 | 5,410,000 | 5,303,000 | 5,127,000 | -5,511,000 | 2,941,000 | 2,940,000 | |
| Shares (Diluted) | 1,183,000 | -60,459,000 | 8,226,000 | 207,000 | 53,361,000 | -5,222,000 | 361,000 | 361,000 | 5,410,000 | -10,526,000 | 5,410,000 | 5,303,000 | 5,127,000 | -5,511,000 | 2,941,000 | 2,940,000 | |
| EBITDA | $-4M | · | $-2M | $-3M | $-3M | · | $-2M | $-5M | $-6M | · | $-6M | $-5M | $-5M | · | $-8M | $-14M |
Balance general 23
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $2M | $3M | $4M | $2M | $2M | $4M | $3M | $5M | $8M | $5M | $2M | $5M | $11M | $13M | $19M | |
| Prepaid Expense | $783.0K | $404.0K | $179.0K | $323.0K | $137.0K | $186.0K | $279.0K | $769.0K | $697.0K | $2M | $704.0K | $1M | $471.0K | $1M | $2M | $2M | |
| Current Assets | $6M | $3M | $3M | $5M | $2M | $2M | $5M | $4M | $6M | $10M | $7M | $4M | $7M | $14M | $16M | $22M | |
| PP&E (Net) | $82.0K | $94.0K | $92.0K | $50.0K | $67.0K | $85.0K | $105.0K | $654.0K | $710.0K | $493.0K | $173.0K | $193.0K | $215.0K | $236.0K | $231.0K | $424.0K | |
| PP&E (Gross) | · | $291.0K | · | · | · | $257.0K | · | · | · | $607.0K | · | · | · | $268.0K | · | · | |
| Accum. Depreciation | · | $197.0K | · | · | · | $172.0K | · | · | · | $114.0K | · | · | · | $32.0K | · | · | |
| Goodwill | · | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $25.0K | $110.0K | $116.0K | $117.0K | $118.0K | $118.0K | $120.0K | $120.0K | $120.0K | $120.0K | $4M | $1M | $1M | $1M | $819.0K | · | |
| Total Assets | $6M | $6M | $6M | $8M | $5M | $5M | $8M | $46M | $50M | $49M | $52M | $47M | $15M | $22M | $21M | $27M | |
| Accounts Payable | $1M | $1M | $958.0K | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $3M | $1M | $2M | $1M | $1M | |
| Accrued Liabilities | $1M | $898.0K | $859.0K | $938.0K | $1M | $1M | $1M | $2M | $2M | $2M | $5M | $2M | $2M | $4M | $3M | $4M | |
| Short-term Debt | · | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3M | $3M | $2M | $3M | $10M | $3M | $10M | $10M | $8M | $7M | $10M | $7M | $5M | $8M | $7M | $7M | |
| Capital Leases | $182.0K | $277.0K | $346.0K | $376.0K | $419.0K | $477.0K | $534.0K | $36M | $37M | $33M | $35M | $35M | $841.0K | $887.0K | $2M | $2M | |
| Other Non-current Liabilities | $1.0K | $43.0K | $112.0K | $113.0K | $111.0K | $111.0K | $84.0K | $84.0K | $84.0K | $84.0K | · | · | $87.0K | · | $2M | $48.0K | |
| Total Liabilities | $3M | $3M | $3M | $3M | $11M | $4M | $53M | $55M | $53M | $47M | $49M | $43M | $8M | $10M | $12M | $12M | |
| Total Debt | · | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $6.0K | $39.0K | $39.0K | $37.0K | $262.0K | $17.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | $15.0K | $287.0K | |
| Paid-in Capital | $258M | $248M | $248M | $247M | $234M | $233M | $180M | $191M | $190M | $189M | $184M | $179M | $178M | $177M | $170M | $168M | |
| Retained Earnings | $-255M | $-246M | $-244M | $-243M | $-240M | $-232M | $-226M | $-199M | $-194M | $-187M | $-181M | $-175M | $-171M | $-165M | $-161M | $-153M | |
| Stockholders' Equity | $3M | $2M | $4M | $4M | $-6M | $2M | $-45M | $-9M | $-3M | $2M | $4M | $4M | $7M | $12M | $9M | $15M | |
| Liabilities + Equity | $6M | $6M | $6M | $8M | $5M | $5M | $8M | $46M | $50M | $49M | $52M | $47M | $15M | $22M | $21M | $27M | |
| Shares Outstanding | 1,170,000 | 7,854,000 | 7,849,000 | 7,483,000 | 52,250,000 | 3,426,000 | 5,411,000 | 5,411,000 | 5,410,000 | 5,410,000 | 5,410,000 | 5,410,000 | 5,127,000 | 5,127,000 | 2,942,000 | 57,469,000 |
Flujo de Efectivo 11
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9.0K | $13.0K | $17.0K | $17.0K | $18.0K | $19.0K | $37.0K | $44.0K | $39.0K | $22.0K | $20.0K | $21.0K | $21.0K | $17.0K | $40.0K | $68.0K | |
| Stock-based Comp | $320.0K | $333.0K | $293.0K | $368.0K | $502.0K | $410.0K | $405.0K | $423.0K | $282.0K | $165.0K | $174.0K | $214.0K | $689.0K | $397.0K | $476.0K | $879.0K | |
| Other Non-cash | · | · | · | · | $6M | · | · | · | $3M | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-4M | $-1M | $-1M | $-3M | $-2M | $-4M | $-6M | $-2M | $-4M | $-5M | $-6M | $-4M | $-6M | $-5M | $-6M | $-4M | |
| CapEx | $3.0K | $15.0K | · | · | · | $0 | $19.0K | $249.0K | $101.0K | $19.0K | $0 | $0 | $0 | $21.0K | $43.0K | $187.0K | |
| Investing Cash Flow | $-3.0K | $-15.0K | · | · | · | $0 | $-19.0K | $-249.0K | $-97.0K | $-19.0K | $0 | $0 | $0 | $129.0K | $-43.0K | $-87.0K | |
| Stock Issued | · | $0 | $0 | · | · | · | · | · | · | · | $0 | $0 | $0 | $8M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $6.0K | $0 | $26.0K | $5M | $2M | $1M | $4M | $-22.0K | $1M | $8M | $9M | $312.0K | $0 | $8M | $6.0K | $-13.0K | |
| Taxes Paid | · | $0 | $0 | · | · | $1.0K | $0 | $2.0K | · | $0 | $0 | $4.0K | $0 | $7.0K | $0 | $8.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | $-4M | · | · | · | $-6M | · | · | · |
Rentabilidad 8
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 112.3% | -102.1% | -29.8% | · | -135.3% | · | · | · | · | · | |
| Operating Margin | · | · | · | · | · | · | -463.9% | -10491.5% | -12312.8% | · | -10794.1% | · | · | · | · | · | |
| Net Margin | · | · | · | · | · | · | -5462.8% | -11763.8% | -14142.5% | · | -10962.8% | · | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | -5460.4% | -11757.5% | -14134.0% | · | -10978.4% | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | -463.9% | -10491.5% | -12229.8% | · | -10794.1% | · | · | · | · | · | |
| ROA | -57.7% | · | -17.8% | -11.6% | -30.0% | · | -88.7% | -11.8% | -20.5% | · | -15.3% | -12.2% | -21.5% | · | -24.3% | -7.4% | |
| ROE | -104.9% | · | 5.9% | 153.8% | 175.2% | · | 127.2% | 237.3% | -335.0% | · | -90.4% | -48.4% | -43.9% | · | -67.0% | -13.6% | |
| ROIC | · | · | -56.1% | -56.3% | 73.9% | · | 5.0% | 57.9% | 169.7% | · | -154.3% | -117.8% | -72.1% | · | -94.3% | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | · | 1.6 | 1.8 | 0.2 | · | 0.5 | 0.4 | 0.8 | · | 0.7 | 0.5 | 1.2 | · | 2.1 | 3.1 | |
| Quick Ratio | 1.7 | · | 1.4 | 1.6 | 0.2 | · | 0.4 | 0.3 | 0.7 | · | 0.5 | 0.3 | 1.0 | · | 1.8 | 2.7 | |
| Debt / Equity | · | · | · | · | -0.4 | · | · | · | · | · | · | · | · | · | · | · |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | · | · |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $632.0K | · | $632.0K | $632.0K | $632.0K | · | $632.0K | · | · | · | · | · | · | · | · | $9M | |
| Net Income TTM | $-14M | · | $-39M | $-43M | $-47M | · | $-44M | $-22M | $-22M | · | $-23M | $-21M | $-26M | · | $-106M | $-109M | |
| Market Cap | $83.4K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -36030.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | — | $582.0K | $68.0K | $0 | — |
| Margen Bruto % | — | 83.5% | — | — | — |
| Margen Operativo % | — | -2693.1% | — | — | — |
| Beneficio neto | $-14M | $-45M | $-22M | $-25M | $-123M |
| EPS Diluido | $-2.24 | $-48.96 | $-4.08 | $-8.06 | $-56.61 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 1.0 | 0.8 | — | 1.8 | — |
| Ratio Rápido | 0.6 | 0.6 | — | 1.5 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-7M | $-16M | — | $-21M | $-24M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 6 declarantes · $202K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 1 | 0 | 1 | 2 | — |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado. Cambio vs trimestre anterior no mostrado: la cobertura de los presentadores difiere demasiado entre estos dos trimestres para una comparación fiable.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Bleichroeder LP | $142 600 | 2 000 000 | 70,50% | Acciones |
| HEIGHTS CAPITAL MANAGEMENT, INC | $28 520 | 400 000 | 14,10% | Acciones |
| ARMISTICE CAPITAL, LLC | $11 408 | 160 000 | 5,64% | Acciones |
| Clear Street Group Inc. | $10 659 | 149 499 | 5,27% | Acciones |
| Warberg Asset Management LLC | $4 950 | 69 430 | 2,45% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4 128 | 57 890 | 2,04% | Acciones |
Activistas y propietarios del %+ 5 7 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Charles Cherington | 22 de diciembre de 2023 | — | Presentación inicial | — | SEC |
| Ault Global Holdings, Inc. ×2 presentaciones | 22 de febrero de 2021 | — | Presentación inicial | — | SEC |
| Matador Capital Partners, L.P., BFK Investments LLC, Jeffrey A. Berg ×3 presentaciones | 15 de junio de 2020 | — | Presentación inicial | — | SEC |
| North Star Investment Management Corporation ×2 presentaciones | 8 de enero de 2020 | — | Presentación inicial | Inversión pasiva | SEC |
| Ram Krishnan | 6 de febrero de 2018 | — | Presentación inicial | — | SEC |
| BFK Investments LLC, Jeffrey A. Berg, Matador Capital Partners, L.P. | 14 de enero de 2011 | — | Presentación inicial | Inversión pasiva | SEC |
| Trinad Capital Master Fund, Ltd., Trinad Management, LLC, Trinad Capital LP, Trinad Advisors II, LLC, Robert S. Ellin, Jay A. Wolf | 24 de julio de 2007 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.